The table below shows Caribou Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$2.40M
$2.20M
$2.67M
$2.35M
$2.02M
$3.46M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$20.61M
$22.40M
$27.69M
$35.53M
$30.42M
$35.48M
SG&A
CRBU annual revenue (10-K history)
Caribou Biosciences, Inc. reported annual revenue of $11.16M for fiscal year 2025. That is up 11.7% from $9.99M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $5.79M (FY 2019) to $11.16M. Figures come from the company's audited annual reports as filed with the SEC.